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Axonal sprouting and synaptic reorganization within the temporal lobe following neuronal injury have been 
implicated in the pathogenesis of temporal lobe epilepsy (TLE). The molecular species responsible for these 
structural changes have yet to be fully defined. The recent characterization f molecules whose normal 
function within the nervous ystem is to inhibit neurite outgrowth and synaptogenesis prompts the suggestion 
that a diminution or loss of such molecules might be of relevance to the pathogenesis ofTLE. If so, the 
possibility of developing a novel therapeutic approach to TLE, distinct from currently available symptomatic 
therapies, to arrest he pathogenetic processes is also raised. 
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INTRODUCTION 
Approximately 40% of all cases of epilepsy take 
the form of complex partial seizures (CPS) 1, the 
majority of which originate within the tem- 
poral lobe. Patients with this epileptic syn- 
drome have a less favourable prognosis for 
seizure control compared to those with general- 
ized seizures, 30% of the former remaining 
intractable to symptomatic medical therapy 2.
Although a larger number of such patients 
than heretofore may benefit from surgical 
intervention, the statistics nonetheless uggest 
that there remains aneed for novel therapeutic 
modalities to control or prevent he develop- 
ment of complex partial seizures of temporal 
lobe origin. 
Epileptic phenomena re characterized by 
neuronal hyperexcitability and paroxysmal 
discharge of cortical neurones. Neurophysio- 
logical studies in both animal models and man 
suggest hat such excessive and abnormally 
synchronous firing of neurones results from a 
concurrent enhancement of excitatory synaptic 
transmission and a decrease in inhibitory 
synaptic transmission, the resulting imbalance 
leading to neuronal hyperexcitability 3. These 
changes in synaptic transmission are mediated 
by the neurotransmitters glutamate and ~- 
aminobutyric a id (GABA), respectively 3. 
Despite this understanding of the neurophy- 
siology and neurochemistry of the epileptic 
temporal obe, relatively little is currently 
known about underlying neuroanatomical 
changes. The commonest neuropathological 
change, seen in the temporal lobes of around 
50% of individuals with complex partial seiz- 
ures 4, is variously known as Ammon's horn 
sclerosis (AHS), incisural sclerosis, mesial 
temporal sclerosis or hippocampal sclerosis. 
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Macroscopical features include fibrous gliosis, 
shrinkage and atrophy, whilst microscopically 
there is a patterned neuronal oss affecting 
principally the pyramidal cell layers in the 
hippocampal subfields CA1, CA3, and in the 
dentate hilus, but sparing the granule cells of 
the dentate gyrus (or fascia dentata) and some 
pyramidal cells in hippocampal region CA2 4'5 
(hippocampal nomenclature of Lorente de No6). 
In addition to cell loss, neuronal impregnation 
studies using the Golgi technique have shown 
dendritic changes in the epileptic hippocam- 
pus 7. DeLorenzo and Glaser observed a 
dramatic reorganization f both dendritic and 
axonal projections from pyramidal and other 
neurones within the hippocampus, uggesting 
the formation of new neuronal processes and 
synaptic ontacts in addition to neuronal loss 
in the hippocampus s. Hence, they advanced the 
hypothesis that reactive neuronal plasticity, 
occurring in response to neuronal injury and 
degeneration, might play a role in the develop- 
ment and persistence ofthe epileptic state s'9. 
SPROUTING AND NEURONAL PLASTICITY 
In the vertebrate peripheral nervous ystem, 
injured axons have the capacity to regenerate 
by sprouting from intact nodes of Ranvier 
(nodal sprouting) or from the terminals of 
injured axons themselves (terminal sprouting). 
Axonal elongation through remaining 
Schwann cell tubes permits reconstitution of
appropriate synaptic contacts (homotypic 
sprouting) and full restoration of function. 
Undamaged axons can also sprout collateral 
branches in response to partial deafferen- 
tation, and these collateral sprouts are able to 
fill vacated synaptic contacts (heterotypic 
sprouting) thus reorganizing synaptic, cir- 
cuitry l°. This neuronal plasticity probably 
underlies the ability of many sub-mammalian 
vertebrates toachieve functional regeneration 
following central nervous system (CNS) 
injury 11, and may be the physiological corre- 
late of learning and memory. 
In contrast to the peripheral nervous ystem, 
damaged axons in the mammalian CNS 
usually fail to regenerate, principally because 
the mammalian CNS environment is inimical 
to axonal elongation following injury 11. Col- 
lateral sprouting does occur, but axon 
elongation to re-establish appropriate synaptic 
targets is often not possible because of the non- 
permissive nature of the CNS environment. 
Aberrant, heterotypic, local synapses may, 
however, be formed. This synaptic reorganiz- 
ation may account for the limited functional 
recovery seen after mammalian CNS injury, 
but it may also have less beneficial conse- 
quences, for example the development of spas- 
ticity is often ascribed to heterotypic sprouting. 
Sprouting is thus a ubiquitous feature of 
neuronal injury, whose functional conse- 
quences may be beneficial, neutral or detri- 
mental, depending on the precise situation in 
which it occurs. 
NEURITE GROWTH-INHIBITORY FACTORS 
The paucity of regeneration following injury to 
the mammalian CNS as compared to sub- 
mammalian vertebrates has been chiefly 
ascribed to the constitutively non-permissive 
nature of the mammalian CNS environment 
for axonal regeneration. It is probable that this 
non-permissive environment is due, at least in 
part, to the presence of cell-surface and 
diffusible molecules which inhibit nerve out- 
growth 12'13. A number of nerve growth- 
inhibitory factors (NGIFs) have been described 
recently," some of which have been partially 
characterized at the molecular level (Table 1). 
As the description of NGIFs is in its infancy, 
more candidate NGIFs are likely to be dis- 
covered in the future. 
Schwab and his colleagues have identified 
two proteins associated with oligodendrocytes 
and myelin in mammalian CNS which inhibit 
neurite outgrowth 14 and cause collapse of 
Table 1 : Candidate neurite growth-inhibitory molecules 
Source Name Reference 
Chick posterior halfsomite - -  20 
Chick posterior optic tectum --  21 
Chick brain Collapsin 22 
Various CSPG 12 
Astrocytes Cytotactin 12 
Mammalian myelin NI35, NI250 14 
Human astrocytes GIF 24 
? H-sema III 23 
Mammalian myelin MAG 12 
Various T-cadherin 12 
Abbreviations: GIF, Growth Inhibitory Factor; CSPG, 
Chondroitin Sulphate Proteoglycan; MAG, Myelin 
Associated Glycoprotein. 
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neuronal growth cones in vitro 15. These pro- 
teins are expressed at lower levels in the CNS 
of fish, in which spontaneous regeneration does 
occur, but are not up-regulated by injury as in 
the mammalian CNS 16. Antibodies to these 
myelin-associated inhibitors allow more exten- 
sive axonal regeneration following CNS 
lesions in mammals 17and more extensive col- 
lateral sprouting into denervated areas is. 
Studies of developmental phenomena have 
provided further examples of neuronal growth- 
inhibitory factors, which are thought o play 
important roles in axonal guidance 19. As motor 
and sensory axons first emerge from the spinal 
cord they are confined to the anterior half of 
the adjacent paraxial mesoderm of the somite 
due to the presence in the posterior half-somite 
of a growth-inhibitory glycoprotein which 
causes growth cone collapse in vitro 2°. The pre- 
cise patterning of axons arriving in the pos- 
terior and anterior tectum from the nasal and 
temporal axons only 21. Chondroitin sulphate 
proteoglycans (CSPGs) are also candidate 
repellent molecules, having been associated 
with neurite avoidance behaviour in a number 
of systems, as have other extracellular matrix 
glycoproteins such as cytotactin (tenascin) ~2. 
with neurite avoidance behaviour in a number 
of systems, as have other extracellular matrix 
glycoproteins such as cytotactin (tenascin) ~2. 
Raper and his colleagues have recently char- 
acterized a protein from embryonic and adult 
chick brain which induces paralysis and col- 
lapse of growth cones in vitro 22. Although its 
in-vivo functions are not definitely known, col- 
lapsin is homologous to fasciclin IV, an axon 
guidance molecule found in grasshoppers. That 
such proteins may be of general relevance was 
indicated by the finding of genes encoding 
similar proteins in Drosophila, grasshopper, 
chick and human, designated the 'semaphorin' 
family 23. The human homologue, H-sema III, 
has not yet been isolated, nor has its functional 
activity been defined. 
It is probable that a number of classes of 
neuro-inhibitory molecules exist in verte- 
brates. A 68-amino acid protein of astrocytic 
origin which can inhibit neurite outgrowth 
(GIF) has been characterized from normal 
human brain 24'25. The possibility that 
derangement of NGIFs might be involved in 
the pathogenesis of certain diseases of the ner- 
vous system is suggested by the observation 
that GIF is deficient in Alzheimer's disease 
brain 24, in which a cortical sprouting response 
is characteristically seen. 
AXONAL SPROUTING AND SYNAPTIC 
REORGANIZATION IN TLE 
Evidence to support the hypothesis that 
neuronal plasticity underlies the development 
and persistence ofTLE 9 has been forthcoming 
from both animal models and clinical material. 
The granule cells within the dentate gyrus 
normally project heir axons, the mossy fibres, 
to the giant pyramidal neurones of the adjac- 
ent CA3 subfield of the hippocampus e. Lesion 
studies have shown that following damage to 
pyramidal cells in CA3, mossy fibres may 
sprout axon collaterals into the inner molecu- 
lar layer of the dentate gyrus where the den- 
drites of granule cells are normally 
situated 26'27. Such a recurrent pathway could 
theoretically lead to abnormal excitatory input 
to dentate granule cells ('feedback excitation'), 
and hence constitute a plausible anatomical 
substrate for the development of repetitive 
electrical discharge, neuronal hyperexcit- 
ability and epileptic seizures. 
This sprouting response may be demon- 
strated using various markers for mossy fibres 
and their axon collaterals. The high zinc con- 
tent of mossy fibres permits their visualization 
by Timm-sulphide histochemistry 2s. Mossy 
fibres are excitatory, and high densities of ex- 
citatory amino acid receptors are found in 
regions to which they project (for example 
CA3), particularly in their terminal arboriz- 
ation. Kainic acid (KA) binding sites are 
located presynaptically on mossy fibre termi- 
nals, and hence an increased ensity of high 
affinity KA binding sites is also a marker of 
mossy fibre sprouting. Immunohistochemistry 
for dynorphin A, an opioid peptide contained 
and released i~y mossy fibres and which can 
generate epileptiform activity in the CA3 
region, may also be used to demonstrate 
sprouting. These techniques have been used to 
provide vidence indicative of sprouting within 
the epileptic, as well as the experimentally 
lesioned, hippocampus. 
ANIMAL MODELS: KAINIC ACID AND 
KINDLING 
The discovery that administration of the 
potent limbic convulsant kainic acid (KA) to 
rats produces lesions remarkably similar to 
human mesial temporal sclerosis has provided 
a useful model system for the study of TLE 29. 
After KA-induced lesions, axons of the dentate 
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granule cells (mossy fibres) are observed to 
sprout collateral fibres which grow across the 
granule cell layer to form a plexus in the inner 
molecular layer of the granule cell dendrites 3°. 
Although this recurrent pathway may seem a 
plausible and attractive neuroanatomical ex- 
planation for seizure activity, the exact re- 
lation of structural change to functional 
consequence remains a critical question. 
Although evidence has been presented sug- 
gesting that these synaptic rearrangements do 
promote seizure activity 3°'31 the case is not en- 
tirely proven. Changes are unlikely to be con- 
fined solely to the mossy fibres: other neuronal 
systems are also likely to sprout, for example 
GABAergic fibres 32, suggesting that anomal- 
ous inhibitory synapses, as well as excitatory 
synapses may contribute to hyperexcitability. 
Indeed, Sloviter has advanced evidence sug- 
gesting that hyperexcitability precedes den- 
tate synaptic reorganization, and is associated 
with a selective loss of interneurones which is 
presumably the stimulus for axon sprouting ~3. 
According to this interpretation, mossy fibre 
sprouts innervate the GABAergic basket cells 
of Cajal, the most important ype of inter- 
neurone in the hippocampus, soenhancing the 
inhibition of granule cells, thus producing a
primarily inhibitory, and hence beneficial, 
rather than epileptogenic, effect. The obser- 
vations of Cronin et al go some way to 
reconciling the disparate viewpoints: their 
observations that GABAA receptor antagonists 
produce synchronous bursts in granule cells 
only in hippocampal slices which show sprout- 
ing suggests that both recurrent inhibitory and 
excitatory circuits are formed, the latter 
emerging only when GABA-mediated synaptic 
inhibition is lost 34. 
Similar morphological observations have 
been made in a further model of TLE, namely 
the kindled rat 3s. Administration of repeated 
subconvulsive electrical or chemical stimuli to 
the hippocampal fferent pathways eventually 
produces eizures of increasing intensity and a 
permanent susceptibility to seizures, the kin- 
dled state. Such altered functional activity in 
the hippocampus results in morphological 
sprouting of mossy fibres into the supragranu- 
lar zone of the dentate gyrus as evidenced by 
Timm histochemistry 3e, presumably as a 
result of altered gene expression (vide infra). 
Moreover, the initial appearance ofmossy fibre 
synaptic terminals in the supragranular layer 
occurs four days after the initiation of kin- 
dling, a time course compatible with axon 
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Table 2: Studies of sprouting in human tissue 
Markers of sprouting Reference 
(A) Mossy fibre sprouting 
KA autoradiography 45 
Dynorphin A immunoreactivity 48 
Timm histochemistry 41 
Timm histochemistry and dynorphin A
immunoreactivity 42 
Timm histochemistry 40 
KA/NMDA autoradiography 46 
Timm histochemistry 43 
Timm histochemistry 44 
(B) Other systems investigated 
Immunohistochemistry fo  GABA, 
somatostatin, neuropeptide Y 48 
Immunohistochemistry for glutamate 
decarboxylase (GAD) 50 
Immunohistochemistry fo  peptides: 
somatostatin, CCK, VIP, dynorphin A 49 
GABAA, KA, NMDA receptor 
autoradiography 47 
(C) Functional Studies 
Orthodromic stimulation via perforant path 51 
Abnormal responses to NMDA 52 
Antidromic stimulation of mossy fibres 44 
sprouting 3v. Aberrant Timm staining, reflect- 
ing axon sprouting, progresses in parallel with 
kindling and persists for up to eight months 
after the last kindled seizure. Kindling also 
results in progressive neuronal loss within the 
hippocampus 3s. However, the functional sig- 
nificance of these structural changes, as in the 
KA model, remains to be conclusively defined. 
HUMAN STUDIES 
It has been pointed out that experiments in 
animal models of epilepsy show mechanisms of
models, which cannot necessarily be extrapo- 
lated to human epilepsy 39. It is therefore 
important that, despite the difficulties in 
obtaining adequate control tissues, studies of 
human epileptic hippocampus be undertaken 
to determine whether similar anatomical 
changes occur and what their functional sig- 
nificance might be 3s'4°. 
Studies of human hippocampal tissue re- 
covered either post mortem or ante mortem 
(temporal lobes surgically resected for intrac- 
table epilepsy) have demonstrated changes 
indicative of axonal sprouting and synaptic 
rearrangement i  epileptic tissue (summarized 
in Table 2). Increased Timm staining in the 
supragranular layer of the dentate gyrus has 
been reported by several groups in both 
adult 41-~ and childhood epilepsy 4°. These 
Axonal sprouting and synsptogenesls In temporal lobe epilepsy 253 
qualitative results from Timm histochemistry 
have been complemented by quantitative 
autoradiographic studies of excitatory amino 
acid binding sites. An increased ensity of KA 
receptors was observed in the CA3 region and 
the fascia dentata by Represa et a145, whilst 
Geddes et a146 found an increase in both KA 
and N-methyl-D-aspartate (NMDA) receptors 
in the entorhinal cortex (the source of afferent 
input to the dentate gyrus via the perforant 
pathway) and the dentate gyrus. The latter 
observation was confirmed by McDonald et 
a147. Increased immunoreactivity for dynor- 
phin A has been reported to closely parallel the 
changes in Timm staining 42'4s. 
As with animal models, mossy fibre sprout- 
ing is unlikely to be the only change in the 
human epileptic hippocampus. Immuno- 
histochemical studies have shown loss of the 
peptides somatostatin and neuropeptide Y, 
suggesting a loss of inhibitory interneurone 
connections 4 . Loss of somatostatin producing 
interneurones with up-regulation of dentate 
somatostatin receptors has been reported to be 
a specific and characteristic change in human 
TLE, since levels of other peptides (CCK octa- 
peptide, VIP, dynorphin Al-17) remain 
normal 49. Normal immunoreactivities for 
GABA 4s and for glutamate decarboxylase, the 
GABA synthetic enzyme 5°, have been re- 
ported. Despite this anatomical evidence for 
preservation of the GABAergic system, this 
does not necessarily imply functional nor- 
mality. The changes are similar to those seen 
in the KA model system where loss of GABA- 
mediated inhibition is thought o occur as a 
result of synaptic rearrangement of GABAer- 
gic neurones34; there is some evidence for simi- 
lar pathophysiology in human epileptic 
tissue 51 (vide infra), perhaps econdary to loss 
of interneurones. Furthermore, GABAA recep- 
tors are decreased in certain hippocampal 
areas  47. 
As with animal studies, the critical question 
of the functional significance of these morpho- 
logical changes in human hippocampus is 
uncertain. Suggestive circumstantial evidence 
includes the correlation between surgical 
removal of'sprouted' hippocampus and reduced 
seizure activity 41. More direct evidence is 
forthcoming from the recording of.electrical re- 
sponses from dentate granule cells in resected 
temporal obes following either orthodromic 
(perforant path) or antidromic (mossy fibre 
axons and their collaterals) stimulation. 
Isokawa and Levesque correlated epileptogenic 
responses of individual dentate granule cells to 
applications of NMDA with loss of dendritic 
spines and beading of dendritic shafts 52. These 
changes may be the functional correlate of the 
dendritic abnormalities originally observed by 
Scheibel et al. 7 These hyperexcitable r sponses 
of dentate granule cells may also reflect a de- 
crease in GABA-mediated synaptic inhi- 
bition 51, since similar responses in the normal 
rat hippocampus could only be elicited in the 
presence of the GABAA antagonist bicuculline. 
The correlation of abnormal antidromic field 
responses with extent of mossy fibre reorganiz- 
ation (as judged by degree of Timm staining) in 
a subgroup of TLE patients upports the hy- 
pothesis that mossy fibre terminals in the 
supragranular layers do have functional conse- 
quences which may underpin.seizure activity, 
at least in some patients 44. 
Hence, human studies have borne out the 
animal models which suggest an epileptogenic 
role for axonal sprouting and synaptic reorgan- 
ization in the temporal lobe. 
MOLECULAR FACTORS INVOLVED IN 
SPROUTING 
The molecular factors which induce and modu- 
late dentate granule cell mossy fibre sprouting 
in TLE are currently unknown, but some cir- 
cumstantial experimental evidence has been 
forthcoming. 
The development, survival and maintenance 
of neuronal cells is dependent on retrogradely- 
transported neurotrophic factors, present in 
limiting amounts in target areas. Up- 
regulation of such neurotrophic factors might 
prompt axonal sprouting. A number of experi- 
mental studies have now shown rapid (within 
hours) and selective, but transient (24-48 
hours duration), increases in the expression of 
genes for the neurotrophins erve growth fac- 
tor (NGF) and brain-derived neurotrophic 
factor (BDNF) in dentate granule cells after 
seizures 53-55, but neurotrophin-3 (NT-3) 
mRNA levels fall 54'55. The largest alterations 
are in BDNF mRNA levels, and these elev- 
ations are also seen in areas outside the 
hippocampus 53.mRNAs for the neurotrophin 
receptors trkB and trkC also rise in dentate 
granule cells, but trkA is unaltered sS. 
Lowenstein and colleagues have documented 
an increase in neurotrophic activity in saline 
extracts of homogenized temporal obe from 
KA-treated rats using a neuronal survival 
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assay 66. This activity was significantly in- 
creased 12 hours  at~r kainate treatment, 
peaked after seven days, but was still evident 
after two months. Antibody-neutralization 
assays at seven days suggested that at least 
part of this activity consisted of NGF, most of 
the remainder being ciliary neurotrophic fac- 
tor (CNTF). NGF-like activity has also been 
detected in fresh human cortical tissue 
(resected temporal lobe seizure foci), which can 
be significantly inhibited in a bioassay of sym- 
pathetic neurite outgrowth by polyclonal anti- 
serum to NGF 57. The difficulty in obtaining 
suitable control tissues makes it impossible to 
adjudge whether this activity is elevated. 
Immunoreactivity for molecules related to 
the neural cell-adhesion molecule (NCAM), 
which promotes neurite outgrowth, has been 
found to correlate both spatially and tempor- 
ally with the pattern of Timm staining in the 
KA-treated epileptic rat 58. At the electron 
microscopic level, antibody to NCAM-like 
activity stains both axonal profiles and astro- 
cytes. Hence NCAM may contribute to the 
synaptic rearrangement of mossy fibres seen in 
TLE, as may other adhesion or substrate pro- 
teins such as L158. The detection of increased 
levels of mRNA for the axon growth-associated 
protein GAP-43 in the granule cells of KA- 
treated rats is also consistent with sprouting of 
mossy fibres 59. 
The up-regulation of genes expressing the 
neurotrophins NGF and BDNF after experi- 
mental hippocampal neuronal injury is brief, 
lasting a maximum of 48 hours, and the peak 
of the neurotrophic activity in hippocampal 
extracts, ascribed mainly to NGF, occurs even 
days after injury. Although such changes 
might be adequate to initiate a sprouting re- 
sponse in the injured hippocampus, it is not 
clear whether they would be sufficient to main- 
tain it for a period of months in experimental 
animals 37 or years in man. 
extracellular matrix, but also from a diminu- 
tion in neurite growth-inhibitory factors 
(NGIFs). The constitutively non-permissive 
nature of the mature mammalian CNS to 
axonal growth may suggest hat a loss of in- 
hibitory (NGIF) activity is more important for 
sustained axonal growth and synaptic reorgan- 
ization than a transient increase in neurotro- 
phin expression. An important precedent for 
such a suggestion stems from studies of tissue 
extracts from Alzheimer's diseased (AD) 
brains: AD brain is characterized pathologi- 
cally by a sprouting response of partially deaf- 
ferented neurones throughout he cortical 
neuropil. Using a neuronal survival assay, 
Uchida et al initially described an increase in 
neurotrophic activity in AD brain 6°, but this 
eventually proved to be a loss of a neurite 
growth-inhibitory protein of astrocytic ori- 
gin 24'25. Furthermore, Schwab and Thoenen 
have presented evidence that adult CNS in- 
hibitory activity cannot be overcome by the 
stimulatory effects of neurotrophic factors 61. 
Preliminary experiments using an assay of 
neuronal growth cone collapse, a standard 
assay for detection of neurite growth-inhibi- 
tory molecules 62, have demonstrated abundant 
collapsing activity in detergent extracts of 
homogenized rat hippocampus, but no obvious 
diminution in specific activity in hippocampi 
seven days after intraperitoneal kainic acid, 
although longer time points have yet to be 
tested (Lamer, A.J., Johnson, A.R., Cook, 
G.M.W., Rudge, J.S., Keynes, R.J., unpub- 
lished observations). 
The molecular probes to confirm or refute 
this speculation are only now becoming avail- 
able. For example, it will be interesting to 
learn whether there is increased expression of 
GAP-43 in human epileptic hippocampus, asin 
the KA rat model 59, since increased expression 
of GAP-43 may correlate with loss of myelin- 
associated NGIFs 63. 
A PATHOGENETIC ROLE FOR NGIFs IN TLE? 
The ontogeny of neuronal pathfinding may 
depend on the differential expression of factors 
which are both attractive to and repulsive for 
neuronal growth cones 19. This differential ex- 
pression may be recapitulated in pathological 
states. Hence, a further, intriguing, possibility 
is that axonal sprouting in TLE may result not 
only from increased levels of neurotrophins 
and adhesion molecules of the cell surface and 
A THERAPEUTIC ROLE FOR NGIFs IN TLE? 
Just as an increased understanding of the 
neurophysiology and neurochemistry of epi- 
lepsy has led to the rational development of
new antiepileptic drugs 64, the new insights 
into the neuroanatomical basis of epilepsy 
could also herald the development of a new 
class of reagents for the treatment of epilepsy. 
If aberrant neuronal growth and reorganiz- 
ation of synaptic circuitry is central to the 
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pathogenesis of TLE, then therapy with agents 
whose normal function is to inhibit nerve 
growth and synaptogenesis would seem logical, 
the more so if endogenous NGIF deficiency is 
one of the key molecular determinants of the 
pathogenetic cascade. Data have emerged to 
suggest hat the myelin-associated inhibitors 
characterized bySchwab and his colleagues act 
in the unlesioned CNS to suppress prouting 
and maintain synaptic stability is. Further- 
more, administration f antibodies to these in- 
hibitors is followed by an expanded pattern of 
collateral sprouting into a previously dener- 
vated area  63, suggesting that the normal role 
of these NGIFs may be to restrict postnatal 
plasticity. Hence, exogenous NGIFs and their 
analogues might be used to diminish or pre- 
vent sprouting and so arrest he pathogenetic 
process. 
Studies on a potential therapeutic role for 
NGIFs in TLE will be facilitated by the avail- 
ability of two animal models of the condition, 
namely kainic acid treated and kindled rats 3s. 
Since the time course of axon sprouting has 
been carefully documented in the kindled 
rat 37, it should be feasible to make correlations 
between time of administration ofNGIF ther- 
apy and efficacy in reducing seizures. In- 
tuitively, one might imagine that the greatest 
benefit of NGIFs will be as prophylactic agents, 
preventing or diminishing axon sprouting im- 
mediately after injury to hippocampal neurons. 
The documented latent period between a hip- 
pocampal neuronal insult and the onset of 
axonal sprouting may represent a window of 
therapeutic opportunity for the prophylactic 
use of NGIFs 37. Alternatively, the possibility 
that a long-lasting diminution in the level of 
NGIFs permits axonal sprouting in the hippo- 
campus (vide supra) suggests that exogenous 
NGIF treatment long after the original injury 
may also be of therapeutic value. 
Could NGIFs have a prophylactic and/or 
therapeutic role in human TLE? It is well 
recognized that AHS, the commonest neuro- 
pathological correlate of TLE, is significantly 
associated with a history of febrile convulsions, 
birth injury, and episodes of status epilepti- 
cus 4. These phenomena might be indicators for 
NGIF therapy, but would also encompass 
many individuals who might develop AHS but 
were not destined to subsequently develop 
TLE. It is recognized that although initial 
neuronal damage in the hippocampus is linked 
closely to metabolic and ionic events arising 
during the greatly enhanced neuronal activity 
of a seizure, the consequent glial reaction and 
scarring gradually 'ripen 'es. At some later 
stage these changes may disrupt normal cer- 
ebral activity with the induction of further epi- 
leptic attacks. This 'ripening' period may be 
analogous to the window of therapeutic oppor- 
tunity in animal models 37, but its exact 
duration remains to be defined. The obser- 
vation of dendritic hanges in the human epi- 
leptic hippocampus also Suggests that TLE 
might reflect an ongoing pathological process 7 
rather than resulting from a single, discrete, 
cortical insult early in life as was once thought. 
Such observations further suggest a place for 
NGIF therapy even many years after the onset 
of seizures. Gowers recognized, almost a cen- 
tury ago, that epilepsy is a self-perpetuating 
disease, the abnormal functional activity of 
each seizure occurring in such a way as to fa- 
cilitate the subsequent recurrence ofthe same 
functional activity 66. Loss of NGIFs may be the 
physiological correlate of this self-perpetuat- 
ing activity, and hence exogenous NGIF ther- 
apy may represent a mechanism to abrogate 
this residual effect. 
Which of the NGIFs described might be used 
in a therapeutic trial? Currently, this is an 
academic question since only two NGIFs have 
been defined at both the protein and genetic 
level to date, namely human metallothionein- 
like GIF 24 and chick collapsin 22. Both of these 
molecules, and some of the other NGIFs which 
are as yet only partially characterized, are 
known to be glycoproteins, for example the pos- 
terior half somite-derived protein 2° and the 
posterior tectal membrane protein 21. Proteins 
will not cross the intact blood-brain barrier, so 
obviating the simple approach of intravascular 
injection or infusion therapy and necessitating 
a more invasive approach, namely intra- 
cerebral or intraventricular injection. Such a 
requirement would severely limit the clinical 
acceptability ofNGIF treatment. Linkage to a 
lipid-soluble carrier molecule might circum- 
vent this problem. 
The definition of NGIFs at the protein and 
genetic level 22-25 should be the prelude to the 
characterization f the cellular receptor(s) for 
these proteins. This will be an advance of fun- 
damental importance with many implications. 
It will permit the development of so-called 
'small molecule' ligands, analogues of NGIFs, 
which, unlike proteins, could cross the blood- 
brain barrier following intravascular dminis- 
tration. Such reagents would provide not only 
new therapeutic agents, but also the possibility 
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of functional imaging of axonal sprouting in an 
injured temporal lobe by conjugation of ligands 
with positron emitting isotopes; imaging of 
functional rearrangement after brain injury 
has already proven possible by this method 6v. 
Functional imaging should improve the selec- 
tion of potential candidates for NGIF therapy 
by identifying those in whom sprouting is 
actually occurring (pathogenetic heterogeneity 
in TLE is certainly possible44), and would also 
indicate the distribution and localization of ad- 
ministered ligands within the CNS. 
Kindling, and by extension sprouting, is 
thought o be relevant o the psychopathology 
of TLE as well as epileptogenesis ss, and ma- 
nipulation of various neurotransmitter r cep- 
tor types by drug therapy has occasionally 
resulted in unwanted psychotic effects. NGIF 
therapy, aimed at a neuroanatomical rather 
than a neurochemical target, should hopefully 
avoid this pitfall. 
CONCLUSION 
The study of axonal sprouting and synaptic re- 
organization i  the epileptic hippocampus has 
given new insights into the pathogenesis of
temporal lobe epilepsy. Basic research studies 
have characterized molecules which normally 
function within the CNS to inhibit neurite out- 
growth and synapse formation. These findings 
have prompted the suggestion of both a poss- 
ible pathogenetic role for such molecules in 
temporal lobe epilepsy, and also the possible 
development of novel therapeutic approaches 
utilizing these molecules which aim to dimin- 
ish or prevent he pathogenetic, epileptogenic 
changes. Although still a long way from rou- 
tine clinical application, these studies may 
eventually enable physicians to tackle the 
pathological anatomy of epilepsy, which is 
recognized to reinforce itself with each success- 
ive seizure. 
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